Diabetes Mellitus (DM) Clinical Trial
Official title:
Premix 70/30 Insulin Plus Supplemental Lunch Insulin in Comparison to Basal Plus Prandial Supplemental Scale and Sliding Scale Insulin in Hospitalized Patients With Type 2 Diabetes
Purpose: To compare efficacy and safety of traditional sliding scale insulin (SSI) versus
modified 70/30 insulin versus modified basal plus supplemental scale /bolus insulin regimens
for glycemic control in hospitalized diabetic patients with diabetes.
Methods: In a prospective trial, patients with diabetes will be randomized to receive either
traditional hospital SSI , or twice daily 70/30 insulin plus supplemental lunchtime insulin
for BG ≥ 150 mg/dL or once every night glargine plus three times prandial glulisine for BG ≥
150 mg/dL . 70/30 insulin and glargine will be started respectively at 0.4 and 0.2 U/kg/day
for BG ≤ 200 mg/dL or 0.5 and 0.3 U/kg/day for BG above 200 mg/dL.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05478070 -
Continuous Glucose Monitoring for Personal Protective Equipment Evaluation
|
N/A | |
| Completed |
NCT02034045 -
Expanding Paramedicine in the Community
|
N/A | |
| Completed |
NCT02685384 -
Post ACA Reform: Evaluation of Community Health Center Care of Diabetes
|
||
| Terminated |
NCT03111238 -
The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
|
Phase 3 | |
| Terminated |
NCT03174522 -
The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
|
Phase 3 |